Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-07
2006-03-07
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S300000
Reexamination Certificate
active
07008954
ABSTRACT:
The present invention provides a pharmaceutical composition for use as a Th2 differentiation inhibitor comprising a compound represented by Formula (I):wherein each of ring A, ring B and ring C is an aromatic carbocyclic ring, a heterocyclic ring and the like, X is a single bond, —O—, —CH2—, —NH—, —SO— and the like, Y is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl and the like, each of V1and V2is a single bond, —O—, —NH—, —OCH2— and the like, a prodrug, pharmaceutically acceptable salt or solvate thereof.
REFERENCES:
patent: 5693611 (1997-12-01), Henle et al.
patent: 6087540 (2000-07-01), Kamigauchi et al.
patent: 6562817 (2003-05-01), Tanimoto et al.
patent: 0 933 346 (1999-08-01), None
patent: 0 993 346 (1999-08-01), None
patent: 1 052 238 (2000-11-01), None
patent: 97/39999 (1997-10-01), None
patent: 98/04508 (1998-02-01), None
patent: WO 98/24766 (1998-06-01), None
patent: 99/38829 (1999-08-01), None
Woodfolk et al., PubMed Abstract (Int Arch Allergy Immunol 129(4):277-85), Dec. 2002.
Elias, Airway Remodeling in Asthma, Am. J. Respir. Crit. Care Med. vol. 161, pp. S168-171, 2000.
Jaffar et al., PubMed Abstract (J. Immunol. 169(10):5997-6004), Nov. 2002.
Ji et al., PubMed Abstract (Am J Trop Med Hyg 66(4):338-45), Apr. 2002.
Nikkei Bio Tech., “Nikkei Bio saishin Yougo Jiten; 4thprinting”, Nikkei BP K.K. (Jun. 30, 1995), p. 644, “Helper T cell; Th”.
Tomio Tada et al., “Menekigaku Yougo Jiten; 3th printing”, Saishin Igakusha (Dec. 1, 1995), p. 374, “Lupus nephritis” p. 414, “Myasthenia gravis” p. 587, “Ulcerative colitis”.
Kamigauchi T. et al. “Terprenins, Novel Immunosuppressants Produced byAspergillus candidus”, The Journal of Antibiotics, vol. 51, No. 4, pp. 445-450, Apr. 1998.
Kamugauchi et al., “Terprenins, Novel Immunosuppressants Produced by Aspergillus candidus”, The Journal of Antibiotics, vol. 51, No. 4, pp. 445-450 (1998).
Arimura Akinori
Kawada Kenji
Birch & Stewart Kolasch & Birch, LLP
Shionogi & Co. Ltd.
LandOfFree
Th2 differentiation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Th2 differentiation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Th2 differentiation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568636